Laser-induced thermal coagulation enhances skin uptake of topically applied compounds

2017 ◽  
Vol 49 (6) ◽  
pp. 582-591 ◽  
Author(s):  
C.S. Haak ◽  
J. Hannibal ◽  
U. Paasch ◽  
R.R. Anderson ◽  
M. Haedersdal
Keyword(s):  
Thermal Coagulation ◽  
Skin Uptake

Enhancement of RF Ablation by Combined Use of Ultra-Low Temperature Fluid Cooling and Magnetic Nanoparticles

2010 ◽  
Author(s):  
Zhong-Shan Deng ◽  
Jing Liu
Keyword(s):  
Magnetic Nanoparticles ◽  
Low Temperature ◽  
Bioheat Transfer ◽  
Rf Ablation ◽  
High Electrical Conductivity ◽  
Thermal Coagulation ◽  
Cooling Method ◽  
Tumor Tissues ◽  
Combined Use ◽  
Fluid Cooling

Magnetic nanoparticles with high electrical conductivity have been proved to be effective in enhancing the efficacy of RF ablation. However, the possible carbonization of tissues is an unfavorable factor in achieving greater dimensions of necrosis, because carbonized tissue is a poor conductor, increases impedance and limits propagation area of RF energy. To prevent potential carbonization of tissues surrounding to the heating part of RF electrodes during RF ablation, a new method using ultra-low temperature fluid was proposed for cooling RF electrodes and tissues in the vicinity of RF electrodes in this study. To test its feasibility, the corresponding bioheat transfer process during RF ablation simultaneously applying this cooling method and magnetic nanoparticles was studied through numerical simulations. The results indicate that the cooling method by ultra-low temperature fluid can prevent carbonization of tissues resulted by local high temperature, significantly enlarge the effective heating area and thus actualize highly efficient thermal coagulation to tumor tissues during RF ablation with adjuvant use of magnetic nanoparticles.

scholarly journals HIV-1 Selection by Epidermal Dendritic Cells during Transmission across Human Skin

1998 ◽  
Vol 187 (10) ◽  
pp. 1623-1631 ◽  
Author(s):  
Jeanette C. Reece ◽  
Amanda J. Handley ◽  
E. John Anstee ◽  
Wayne A. Morrison ◽  
Suzanne M. Crowe ◽  
...  
Keyword(s):  
T Cells ◽  
Dendritic Cells ◽  
Human Skin ◽  
Cell Sorting ◽  
Virus Entry ◽  
Skin Explants ◽  
Skin Uptake ◽  
Virus Exposure ◽  
Epidermal Dendritic Cells ◽  
Hiv 1

Macrophage tropic HIV-1 is predominant during the initial viremia after person to person transmission of HIV-1 (Zhu, T., H. Mo, N. Wang, D.S. Nam, Y. Cao, R.A. Koup, and D.D. Ho. 1993. Science. 261:1179–1181.), and this selection may occur during virus entry and carriage to the lymphoid tissue. Human skin explants were used to model HIV-1 selection that may occur at the skin or mucosal surface. Macrophage tropic, but not T cell line tropic strains of HIV-1 applied to the abraded epidermis were recovered from the cells emigrating from the skin explants. Dermis and epidermis were separated by dispase digestion after virus exposure to determine the site of viral selection within the skin. Uptake and transmission to T cells of all HIV-1 isolates was found with the dermal emigrant cells, but only macrophage tropic virus was transferred by emigrants from the epidermis exposed to HIV-1, indicating selection only within the epidermis. CD3+, CD4+ T cells were found in both the dermal and epidermal emigrant cells. After cell sorting to exclude contaminating T cells, macrophage tropic HIV-1 was found in both the dermal emigrant dendritic cells and in dendritic cells sorted from the epidermal emigrants. These observations suggest that selective infection of the immature epidermal dendritic cells represents the cellular mechanism that limits the initial viremia to HIV-1 that can use the CCR5 coreceptor.

Monitoring of thermal coagulation process of tissue using phase modulation spectroscopy

1999 ◽  
Author(s):  
Guiling Wu ◽  
Chenpeng Mu ◽  
Qingming Luo ◽  
Dan Zhu ◽  
Shaoqun Zhen ◽  
...  
Keyword(s):  
Phase Modulation ◽  
Modulation Spectroscopy ◽  
Thermal Coagulation ◽  
Coagulation Process

Changes in backscatter of liver tissue due to thermal coagulation induced by focused ultrasound

2013 ◽  
Vol 134 (2) ◽  
pp. 1724-1730 ◽  
Author(s):  
Takashi Shishitani ◽  
Ryo Matsuzawa ◽  
Shin Yoshizawa ◽  
Shin-ichiro Umemura
Keyword(s):  
Liver Tissue ◽  
Focused Ultrasound ◽  
Thermal Coagulation

Thermal Coagulation Device for Treating Cervical Dysplasia

2018 ◽  
Vol 26 (2) ◽  
pp. 149-152 ◽  
Author(s):  
Ashley Langell ◽  
Timothy Pickett ◽  
Catherine Mangum ◽  
Jennwood Chen ◽  
John Langell
Keyword(s):  
Cervical Cancer ◽  
Cervical Intraepithelial Neoplasia ◽  
Resource Constraints ◽  
Low Cost ◽  
Stakeholder Analysis ◽  
Cervical Dysplasia ◽  
Intraepithelial Neoplasia ◽  
Cervical Cancer Prevention ◽  
User Centered Design ◽  
Thermal Coagulation

Background. Cervical cancer remains a leading cause of cancer-related deaths worldwide despite being a highly preventable disease. Nine out of every 10 deaths due to cervical cancer occur in developing regions with limited access to medical care and unique resource constraints. To address cervical cancer prevention within the confines of these unique limitations, our team of students and faculty advisors at the University of Utah’s Center for Medical Innovation developed a low-cost, portable technology that utilizes thermal coagulation, a form of heat ablation, to treat cervical intraepithelial neoplasia. Methods. A multidisciplinary team of students worked with clinical and industry advisors to develop a globally applicable treatment for cervical intraepithelial neoplasia through a systematic process of problem validation, stakeholder analysis, user-centered design, business plan development, and regulatory clearance. Results. Our efforts resulted in the development of a functional, self-contained, battery-operated prototype within 72 days, followed by Food and Drug Administration clearance of a finalized device within 18 months. Conclusion. Interdisciplinary university programs that leverage the capabilities of academic-industry partnerships can accelerate the development and commercialization of affordable medical technologies to solve critical global health issues.

scholarly journals Minimally Invasive Technologies for Treatment of HTS and Keloids: Pulsed-Dye Laser

2020 ◽  
pp. 263-269
Author(s):  
Sebastian P. Nischwitz ◽  
David B. Lumenta ◽  
Stephan Spendel ◽  
Lars-Peter Kamolz
Keyword(s):  
Minimally Invasive ◽  
New Technology ◽  
Laser Pulses ◽  
Dye Laser ◽  
Pulsed Dye Laser ◽  
Clinical Use ◽  
Hypertrophic Scars ◽  
High Quality ◽  
Thermal Coagulation ◽  
Selective Photothermolysis

AbstractWe present another minimally invasive technology for the treatment of hypertrophic scars and keloids: the pulsed-dye laser. Being first introduced by two groups around Schaefer (Germany) and Sorokin & Lankard (USA) in 1966, the pulsed dye laser is a rather new technology. The first clinical use of pulsed-dye lasers was reported in 1983 for the treatment of naevus flammeus, and was the first laser used for the treatment of keloids in the mid-1990s.Its efficacy is based on the principle of selective photothermolysis, enabling a selective destruction of defined structures absorbing the respective wavelength used, as compared to other lasers working based on thermal coagulation or ablative tissue interaction. The preferred wavelengths being used are 585 or 595 nm, which makes small cutaneous vessels the main targets. Their destruction leads to a diminished blood supply of the irradiated area, thus reducing symptoms of hypertrophic scars like itching, vascularity, and redness, and secondary – probably by the induced hypoxemia – a reduction in scar height and pliability. This therapeutic approach also implies the use of pulsed-dye laser in the prevention of pathologic scars. While significant side effects are usually rare, slight signs of use like edema or scab formation can pertain for several days. Since the sensory impact of laser pulses are comparable to needle pricks, some form of analgesia during the application is highly recommended. The elusive data and still existing scarcity of high-quality studies on the use of pulsed-dye laser, however, make it hard to develop clear recommendations.

scholarly journals Internal and External Radiofrequency Assisted Lipo-Coagulation (RFAL) in the Control of Soft Tissue Contraction during Liposuction: Part 2 “Outside In” RFAL Thermal Tissue Tightening

2021 ◽  
Author(s):  
Robert Stephen Mulholland
Keyword(s):  
Soft Tissue ◽  
Invasive Procedure ◽  
Thermal Stimulation ◽  
Thermal Coagulation ◽  
Soft Tissue Envelope ◽  
Non Invasive ◽  
Tissue Contraction ◽  
Contraction Effect ◽  
Positively Charged ◽  
Coated Electrodes

The new Morpheus8 is a novel external RFAL device that uses the proven soft tissue contraction of BodyTite in an external, non-invasive procedure. This external RF applicator, which is also powered by BodyTite, inserts up to 40 positively charged, coated electrodes 8 mm into the subcutaneous, soft tissue envelope. A monopolar ablative lesion is generated from the tip of the electrode, stimulating contraction of the FSN and adipose coagulation. The RF then flows up to the distant negative, return electrodes on the surface of the skin, providing a non-ablative thermal stimulation to the papillary dermis. The “burst” feature of the Morpheus8, delivers simultaneous multiple levels of internal coagulation in a single one second pulse, amplifying the adipose ablation and contraction effect. Studies, show, that the combination of BodyTite internal thermal coagulation and external Morpheus8 at the time of liposuction can result in 60–70% area skin contraction, greatly improving the soft tissue contours and Body shaping outcomes following lipo-contouring procedures.

The thermal coagulation point of blood serum

1950 ◽  
Vol 8 (6) ◽  
pp. 755-758
Author(s):  
George B.Jerzy Glass
Keyword(s):  
Blood Serum ◽  
Thermal Coagulation
Sign in / Sign up

Export Citation Format

Share Document